ReviewCare of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
Under a Creative Commons license
open access
Abbreviations
ACE2
angiotensin-converting enzyme 2
ACE-I
angiotensin-converting enzyme inhibitor
ACLF
acute-on-chronic liver failure
ALT
alanine aminotransferase
AST
aspartate aminotransferase
COVID-19
coronavirus disease 2019
EGD
esophagogastroduodenoscopy
ERC
endoscopic retrograde cholangiography
HCC
hepatocellular carcinoma
MELD
model for end-stage liver disease
NAFLD
non-alcoholic fatty liver disease
NASH
non-alcoholic steatohepatitis
NUC
nucleoside analogue
PIs
protease inhibitors
RdRp
RNA-dependent RNA polymerase
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
ULN
upper limit of normal
Cited by (0)
Author names in bold designate shared co-first authorship
© 2020 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).